UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred

Journal of human genetics, 2004, Vol.49 (1), p.29-34

2004

Link zum Volltext

Verfügbarkeit prüfen

Putting Into Perspective the Hazards of Untreated Familial Hypercholesterolemia

Journal of the American Heart Association, 2017-06, Vol.6 (6)

Hopkins, Paul N

2017

Link zum Volltext

Verfügbarkeit prüfen

Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36[S]

Journal of lipid research, 2016-12, Vol.57 (12), p.2176-2184

2016

Link zum Volltext

Verfügbarkeit prüfen

High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study

Lipids in health and disease, 2011-10, Vol.10 (1), p.181-181, Article 181

2011

Link zum Volltext

Verfügbarkeit prüfen

A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree

Human genetics, 2004-03, Vol.114 (4), p.349-353

2004

Link zum Volltext

Verfügbarkeit prüfen

An exome-wide sequencing study of lipid response to high-fat meal and fenofibrate in Caucasians from the GOLDN cohort

Journal of lipid research, 2018-04, Vol.59 (4), p.722-729

2018

Link zum Volltext

Verfügbarkeit prüfen

Sex-Specific Association of the Putative Fructose Transporter SLC2A9 Variants With Uric Acid Levels Is Modified by BMI

Diabetes care, 2008-08, Vol.31 (8), p.1662-1667

2008

Link zum Volltext

Verfügbarkeit prüfen

A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network

Pharmacogenetics and genomics, 2012-03, Vol.22 (3), p.191-197

2012

Link zum Volltext

Verfügbarkeit prüfen

Variants Identified in a GWAS Meta-Analysis for Blood Lipids Are Associated with the Lipid Response to Fenofibrate

PloS one, 2012-10, Vol.7 (10), p.e48663

2012

Link zum Volltext

Verfügbarkeit prüfen

Relation between Erythrocyte Trans Fat and Triglyceride, VLDL- and HDL-Cholesterol Concentrations Depends on Polyunsaturated Fat

PloS one, 2012-10, Vol.7 (10), p.e47430-e47430

2012

Link zum Volltext

Verfügbarkeit prüfen

An Exome-Wide Sequencing Study of the GOLDN Cohort Reveals Novel Associations of Coding Variants and Fasting Plasma Lipids

Frontiers in genetics, 2019-02, Vol.10, p.158-158

2019

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody

Circulation. Cardiovascular genetics, 2015-12, Vol.8 (6), p.823

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia

Journal of clinical lipidology, 2017-11, Vol.11 (6), p.1338-1346.e7

2017

Link zum Volltext

Verfügbarkeit prüfen

Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred

Arteriosclerosis, thrombosis, and vascular biology, 2000-04, Vol.20 (4), p.1089

2000

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS

Lipids in health and disease, 2011-08, Vol.10 (1), p.143-143

2011

Link zum Volltext

Verfügbarkeit prüfen

Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study

Circulation (New York, N.Y.), 2003-08, Vol.108 (5), p.519-523

2003

Link zum Volltext

Verfügbarkeit prüfen

Genetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicity

Human genetics, 2013-04, Vol.132 (4), p.405-413

2013

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide association studies identified novel loci for non-high-density lipoprotein cholesterol and its postprandial lipemic response

Human genetics, 2014-07, Vol.133 (7), p.919-930

2014

Link zum Volltext

Verfügbarkeit prüfen

Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred

Journal of human genetics, 2002-12, Vol.47 (12), p.656-664

2002

Link zum Volltext

Verfügbarkeit prüfen

Replication and meta-analysis of the gene-environment interaction between body mass index and the interleukin-6 promoter polymorphism with higher insulin resistance

Metabolism, clinical and experimental, 2012-05, Vol.61 (5), p.667-671

2012

Link zum Volltext

Verfügbarkeit prüfen

Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease

Arteriosclerosis, thrombosis, and vascular biology, 1996-02, Vol.16 (2), p.250

1996

Link zum Volltext

Verfügbarkeit prüfen

INSIG2 Polymorphism Is Neither Associated With BMI Nor With Phenotypes of Lipoprotein Metabolism

Obesity (Silver Spring, Md.), 2008-04, Vol.16 (4), p.827-833

2008

Link zum Volltext

Verfügbarkeit prüfen

Growth hormone receptor variant (L526I) modifies plasma HDL cholesterol phenotype in familial hypercholesterolemia: Intra-familial association study in an eight-generation hyperlipidemic kindred

American journal of medical genetics, 2003-08, Vol.121A (2), p.136-140

2003

Link zum Volltext

Verfügbarkeit prüfen

Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study

Atherosclerosis, 2001-02, Vol.154 (3), p.747-754

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals

ThemaArterial Hypertension. Arterial Hypotension

ThemaGenetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(41)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred

Putting Into Perspective the Hazards of Untreated Familial Hypercholesterolemia

Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36[S]

High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study

A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree

An exome-wide sequencing study of lipid response to high-fat meal and fenofibrate in Caucasians from the GOLDN cohort

Sex-Specific Association of the Putative Fructose Transporter SLC2A9 Variants With Uric Acid Levels Is Modified by BMI

A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network

Variants Identified in a GWAS Meta-Analysis for Blood Lipids Are Associated with the Lipid Response to Fenofibrate

Relation between Erythrocyte Trans Fat and Triglyceride, VLDL- and HDL-Cholesterol Concentrations Depends on Polyunsaturated Fat

An Exome-Wide Sequencing Study of the GOLDN Cohort Reveals Novel Associations of Coding Variants and Fasting Plasma Lipids

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody

Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia

Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred

Lipoprotein lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS

Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study

Discovery and fine-mapping of loci associated with MUFAs through trans-ethnic meta-analysis in Chinese and European populations[S]

Genetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicity

Genome-wide association studies identified novel loci for non-high-density lipoprotein cholesterol and its postprandial lipemic response

Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred

Replication and meta-analysis of the gene-environment interaction between body mass index and the interleukin-6 promoter polymorphism with higher insulin resistance

Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease

INSIG2 Polymorphism Is Neither Associated With BMI Nor With Phenotypes of Lipoprotein Metabolism

Growth hormone receptor variant (L526I) modifies plasma HDL cholesterol phenotype in familial hypercholesterolemia: Intra-familial association study in an eight-generation hyperlipidemic kindred

Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study

Aktive Filter

Suchergebnisse filtern